chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report initially received from a contactable physician via a Pfizer Field Force Representative with follow-up from the nurse at the office. A 3-year-old male received the first dose of PREVNAR13 on 28MAR2011 via an intramuscular route of administration in the right thigh. There was no relevant medical history, no drug history, no drug allergies and no family history. No concomitant medications were noted. The patient was reported to be up-to-date on his vaccinations. The patient experienced facial flushing 30 minutes after vaccination. The patient returned to the physician's office 30 minutes after  vaccinations and was treated with BENADRYL. At the time of this report, the patient had recovered. The physician believes that there was a reasonable possibility that the event was related to PREVNAR13. Follow-up attempts completed. No further information expected. Follow-up (22APR2011): New information reported from a contactable nurse includes: gender of patient, dose details, onset of event, treatment outcome and causality assessment. Follow-up (19MAY2011): Follow-up attempts completed. No further information expected.
Pt recvd vax 13NOV92 & exp burning w/the inject & stated that felt the vax going in; also exp pain in arm & into shoulder; 1 1/2 hrs following vax devel nausea, fatigue, fever of 103, was unable to lift arm higher than 10"; exp pain;
One week after vaccination, patient is experiencing a delayed allergic reaction at the site of injection (left arm). Swollen, red rash, tenderness. The size is about the size of a baseball. Patient had no allergy signs until about a week after vaccination.  Benadryl, cold compress, and rx topical steriod perscriped. Photo documentation for tracking Monitor rash for changes
Headache; This is a spontaneous report from the Pfizer Sponsored Program received by a contactable consumer (patient husband).  A female patient (age not provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 10Jan2021 at single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. In Jan2021, after vaccination, the patient developed headache. The reported asked if she could take acetaminophen. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested.
she is in a prolonged flare up, and it has gotten worse; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: ER8730), via an unspecified route of administration on 23Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunization. Medical history included ulcerative colitis from an unspecified date, ongoing ulcerative colitis flare-up from Jan2020 and lost weight because of the flare-up. Concomitant medications were not reported. On an unspecified date, the patient experienced a worsening of her prolonged ulcerative colitis flare-up. She had been advised by her doctor to start a high dose of prednisone (40 mg), one week from now, for her condition. The doctor did not want or feel comfortable with the patient waiting for 2 weeks after the shot to start the prednisone, her condition necessitated she take the prednisone now. She had not previously gone on higher doses of prednisone for more than 10 days due to the virus. She was due for the second dose of the vaccine and queried whether a moderate to high level of prednisone will interfere with the vaccine. The clinical outcome of "she is in a prolonged flare up, and it has gotten worse" was not resolved.
patient reports left ear pain and swelling in left cheek with pain radiating down face approximately 4 days post vaccination
Patient was given Expired vaccine...No adverse effects noted Patient notified and scheduled to received a repeated dose of MMR. Expired vaccine was MMR- Lot# 0306F-Exp date- 7-4-08
pt recvd vax & exp nausea; 11MAY93 was vax w/2nd dose w/in 30 minutes exp nausea, vomiting, chills & lightheadedness; was unable to tolerate any liquids or foods; pulse 101; fever to 101; h/a; viral studies pos for CMV & UA showed trace bac
The concern is a delayed immune response?  Mild Sinus/throat irritation began on day 5, but fever (102.0) intense headaches and full body aches began on day 10.   I had symptomatic covid in August 2020.   Could not find any info on CDC or Pfizer website regarding how many days after vaccination immune response can begin.
Vomiting, abdominal pain, rash, itching. Patient was taken to ER by ambulance from office. Reaction started occuring within 5 minutes after administration of vaccines.
"0010 - pt c/o itching, burning, rash noted on arms, thighs, back, buttocks, as increase shortness of breath noted.  Dr called Benadryl given then pt started becoming nauseated.  Called Dr back Zofran ordered. Pt did have a flu shot today, but not a pneumo vac. RN"
Missed period over the past 5 months. Last period was from 1/8/21-1/14/21. I received the first dose of the vaccine following my last period. I have not had a period since and I?m not on birth control not pregnant.
Child diagnosed with cellulitis at injection site 2 days after injection.  Completed 5 day course of antibiotics and has improved.
A week before I was scheduled to have my 2nd dose, my symptoms included body chills, body aches and sweating. Found out I had high BP when I went to urgent care which they sent me to the ER, was taking different medications, did a CT scan and found fluid my heart which ended up with me getting admitted in June and got diagnosed with heart failure.
Body aches; Sore muscles; Sore neck; back arm; Tired; Can't sleep; Swollen lymph nodes same armpit as shot; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included slight asthma, COVID-19 on an unknown date and sulfonamide allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient previously received clindamycin (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN), riboflavin (MANUFACTURER UNKNOWN), ergocalciferol (VIT D), tocopherol (VITAMIN E) and ascorbic acid, calcium lactate, copper sulfate, cyanocobalamin, ergocalciferol, ferrous fumarate, nicotinamide, retinol, riboflavin, sodium iodide, sodium molybdate, thiamine mononitrate (NUTREX); all for an unknown indication, from an unknown date and unknown if ongoing.  On  26Feb2021 at 22:00, the patient experienced 24 hours later body aches, sore muscles, sore neck, back arm, was tired, could not sleep and had swollen lymph nodes same armpit as shot. The patient experienced 48 hours sore muscles, swollen lymph nodes same armpit as shot and could not sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, sore muscles, sore neck, back arm, tired, could not sleep and swollen lymph nodes same armpit as shot was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
ACCIDENTALLY GAVE CUSTOMER A MODERNA COVID VACCINE INSTEAD OF THE PFIZER. NO ACTUAL ADVERSE REACTION.
Received the shot around 12:30 PM Tuesday Sept 30th. Started sweating around 4:30 and had to go to bed at 6:30PM. Woke up around 2:30 am with temp of 102.6 and shot arm swelled up and head splitting. Temp started going up so husband packed me in ice and gave me "thera flu". No change in temp. With ice and acetaminophen could not get out of bed and temp stayed around 102 until Friday. Could only keep ice chips and ginger ale down. By Friday night temp broke and was hovering at 101.5. By Saturday I sweated all day with temp around 100. By Sunday temp was normal but still had a splitting headache but swelling arm went down but continued to be red, blotchy and sore. Started vaginally bleeding out of cycle (never happened before) on Saturday...still bleeding on Monday. Need to go to the eye DR too because it seems like my eyes have changed...do not know yet.
Pt experienced an injection site reaction characterized as being red and raised. Pt allowed no touch. 18 X 12-1/2 cm in measurement. Pt treated with zoster and cold compresses.
Information has been received from a registered school nurse concerning a female who was vaccinated with a dose of MMR. It was reported that the nurse received a phone call from a student's parent and during their conversation, the parent stated that he had heard about a girl that received the vaccine and didn't develop right. The girl's outcome was unknown. No product quality complaint was involved. Follow up information noted that the caller stated that a friend of his was vaccinated with MMR and was later retarded at the age of 11 from the shot. Upon internal review, retarded was considered an other important medical event (OMIC). No further information is expected.
Headache, Myalgia, Fever, HA, chills, sweats, low grade fever, joint paint muscle pain Narrative: Received 1/21/21 in am is experiencing ha, chills, low grade temp 100.5 F sweats, body aches, joint pain that started 1/22/21. Self care at home with use of acetaminopin and aleve prn. Starting to feel better as day goes on. Reports signs and symptoms "Are worse this time then when she had covid". Advised to continue to monitor for S&S and f/u with PCP as needed.
menstrual bleeding started earlier and is still bleeding; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetic. Concomitant products included METFORMIN for Pre-diabetic.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding). At the time of the report, HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Rt thigh 1/2 cm area of redness, firm nodule at the PEDIARIX site - no peri tenderness.
Developed itchy rash 6 days post vax in same area of shot with body ache, URI symptoms. Two days later, he developed other lesions, papuli with surrounding erythema and eventual ulcer in center of trunk, chest, and back. Prescribed medication for possible cellulitis.
Sore shoulder and 100 degree fever registered on a Braun thermoscan  and fatigue
1 day swelling of the whole upper arm, red, tender induration. Got better a little bit the next day. Treated w/antibiotics.
first dose of Shingrix roughly a year ago / COVID hit they missed their second dose; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received Shingrix roughly a year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were reported as follows: The age at vaccination was not applicable to this report. The age group was not reported but captured as an adult as per vaccine indication. Patient did not received 2nd dose of Shingrix due to Covid hit. HCP declined to provide date of birth and did not have any additional vaccine information as she was not at work. The reporter consented to follow up. The case is linked with US2021075985, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021075985:same reporter
pt was given 1st varicella on 06/12/2009 pt returned to the office 6/24/2009 with the c/o spots on belly, fever, vomiting. Pt was dx with chicken pox.
Information has been received from a nurse practitioner concerning a female patient who was vaccinated with a second dose of Gardasil. On an unspecified date, the patient reported an itchy rash after her second dose. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. It was reported that the patient told the physician that she had a similar reaction after the first dose, but did not report it until after the second occurrence. No product quality complaint was involved. Additional information has been requested.
She did not feel like herself; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She did not feel like herself) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (She did not feel like herself). At the time of the report, FEELING ABNORMAL (She did not feel like herself) outcome was unknown.            No concomitant medications were provided. No treatment medications were reported. The patient stated that she did not felt like herself after the first and the second dose of the Moderna Covid-19 vaccine. The patient got fully vaccinated with her first two Moderna Covid-19 vaccinations. The patient has not yet received her Moderna Covid-19 booster dose.   This case was linked to MOD-2022-523616 (Patient Link).   Reporter did not allow further contact
I ended up with a Kidney stone two weeks after taking the vaccine. I had intense pain in my right kidney and it was very painful overnight and the following day the nursing line advised that I go to the Doctor's office (stayed home and went to the Doctor's office for testing the next day). My Doctor advised that I passed the stone and to change my diet so it doesn't happen again).
Racing heartbeat and heart palpitations; insomnia; anxiety; brain fog; suicidal ideation
Arrived with vaginal bleeding, 36w5d gestation. Tested positive for COVID which may have precipitated PROM. Reports sore throat x4 days. Delivered by Csection. No target treatment required for COVID infection. Discharged home on POD2.
9 days after MMR patient developed maculopapular rash on face, neck, abd, back and legs. Pt also had fever 2 days prior - patient given MMR at another physician's office and was traveling.
Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 30Jan2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The medical history included chronic fatigue syndrome. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. On 01Feb2021, the patient experienced diarrhea and fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea and fatigue were not recovered at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 21Feb2021 (at the age of 72-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Initial arm soreness resolved after several days.  On day 8 or 9 post-vaccine, hives developed near the vaccine site, followed by redness and swelling.  Soreness returned and lasted at least three days.
Dystheria and general body weakness.  Onset 10/06/2005.  Dysteria resolved on 11/20/2005.  General body weakness resolved on 12/14/2005.  Treatment course was time and multiple test.
Body aches, headache, fatigue, sunburn feeling of skin (no visible markings)
Information has been received from a health professional concerning an 18 year old female patient with seasonal allergies and no pertinent medical history who at age of 2 months, was vaccinated with a 3 dose series of RECOMBIVAX HB (lot number not provided). A hepatitis B titer done at age 6 or 7 years was core antigen negative and surface antigen positive at 20.1mIU/ml. A recent titer was core antigen positive and surface antigen positive at 10.84mIU/ml. The patient sought medical attention in the office. At the time of the report, the patient did not recover from this event. Additional information has been requested.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 4:03 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 21.81 for dose administered on 13-Feb-2021. No concomitant medications were reported.  On 13-Feb-2021, the vaccine with batch number 031L20A was moved to fridge on 09-Feb-2021, 30 vials were moved to the clinic on 13-Jan-2021 at 09:00 AM, vials underwent temperature excursion with temperature of 32 degrees Fahrenheit. The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 10-Mar-2021.  It was reported that, the storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a brand traceable temperature monitor at every hour.  It was reported that, the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree Fahrenheit. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
I had vaccination on 10/03/22.  On 02/02/2023 I started to experience a runny nose loss of voice fatigue. I tested COVID-19 Posted on 02/02/2023. I did start to have dizziness a few days after. I was told to take over the counter medication for fever and aches and to rest at home. I do feel better but the fatigue is still present on 04/05/2023.
This spontaneous report was received from a pharmacist and refers to an unspecified patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant therapies was provided. On 16-DEC2015, the patient was vaccinated with the first dose of MMR II (lot #, expiration date, exact dose and route of administration were not reported). On 18-DEC-2015, the patient accidentally received the second dose of MMR II (lot #, expiration date, exact dose and route of administration were not reported). No adverse effect was reported. No PQC (product quality complaint) was involved. Additional information has been requested.
In approximately 1994, this 58-year-old female received vax. The pt noted that she was 'formerly a nurse's assistant working around Hepatitis B infected pts.' In approximately 1997 the pt was dx with multiple sclerosis. The pt sought unspecified medical attention. Additionally it was noted that the pt considered his condition life threatening and disabling. Additional information has been requested.
The night before I was at a store and a couple in the store in front of me couldn't stop coughing. Neither of us had mask. The next morning I woke up fatigued and drained, I went in for a COVID-19 test after work at pharmacy clinic. The next day I woke up with a migraine and stomach issues. I went to the emergency room for my migraine to get a Toradol, they also tested me COVID-19.
got COVID-19 again, but with no symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got COVID-19 again, but with no symptoms) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Aug-2021, the patient experienced COVID-19 (got COVID-19 again, but with no symptoms). At the time of the report, COVID-19 (got COVID-19 again, but with no symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Aug-2021, SARS-CoV-2 test: negative (Negative) negative COVID test.         No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow up information received and added lab data.